Diphtheria-tetanus-acellular pertussis (DTaP) vaccine
Howe, B.J.
JAMA 276(22): 1803-1804
1996
ISSN/ISBN: 0098-7484
PMID: 8946898
DOI: 10.1001/jama.1996.03540220027023
Accession: 045796237
PDF emailed within 0-6 h: $19.90
Related References
Bartels, I.; Jüngert, J.; Lugauer, S.; Stehr, K.; Heininger, U. 2001: Immunogenicity and reactogenicity of a single dose of a diphtheria--tetanus--acellular pertussis component vaccine (DTaP) compared to a diphtheria--tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults Vaccine 19(23-24): 3137-3145Glanz, J.M.; Narwaney, K.J.; Newcomer, S.R.; Daley, M.F.; Hambidge, S.J.; Rowhani-Rahbar, A.; Lee, G.M.; Nelson, J.C.; Naleway, A.L.; Nordin, J.D.; Lugg, M.M.; Weintraub, E.S. 2013: Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age JAMA Pediatrics 167(11): 1060-1064
Podda, A.; Bona, G.; Canciani, G.; Pistilli, A.M.; Contu, B.; Furlan, R.; Meloni, T.; Stramare, D.; Titone, L.; Rappuoli, R. 1995: Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine Journal of Pediatrics 127(2): 238-243
Daley, M.F.; Yih, W.K.; Glanz, J.M.; Hambidge, S.J.; Narwaney, K.J.; Yin, R.; Li, L.; Nelson, J.C.; Nordin, J.D.; Klein, N.P.; Jacobsen, S.J.; Weintraub, E. 2014: Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine Vaccine 32(25): 3019-3024
Lee, S.Y.; Hwang, H.S.; Kim, J.H.; Kim, H.H.; Lee, H.S.; Chung, E.H.; Park, S.E.; Ma, S.H.; Chang, J.K.; Guitton, F.; Ortiz, E.; Kang, J.H. 2011: Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea Vaccine 29(8): 1551-1557
Ujiie, M.; Tsuzuki, S.; Suzuki, M.; Ota, M.; Suzuki, T.; Nomoto, H.; Yamamoto, K.; Saito, S.; Kokaze, A.; Kinoshita, N. 2021: Safety of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccine in Adults in Japan Japanese Journal of Infectious Diseases 74(5): 399-404
Campbell, N.S.; Kalman, D.D. 2019: Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 123(4): 409-411
Mawas, F.; Dickinson, R.; Douglas-Bardsley, A.; Xing, D.K.L.; Sesardic, D.; Corbel, M.J. 2006: Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model Vaccine 24(17): 3505-3512
Lee, C.Y.; Thipphawong, J.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Lin, W.; Debois, H.; Harrison, D.; Xie, F.; Barreto, L. 1999: An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants Pediatrics 103(1): 25-30
Okada, K.; Miyazaki, C.; Kino, Y.; Ozaki, T.; Hirose, M.; Ueda, K. 2013: Phase Ii and IIi Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV) Journal of Infectious Diseases 208(2): 275-283
Hoppenbrouwers, K.; Kanra, G.; Roelants, M.; Ceyhan, M.; Vandermeulen, C.; Yurdakök, K.; Silier, T.; Dupuy, M.; Pehlivan, T.; Ozmert, E.; Desmyter, J. 1999: Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey Vaccine 17(7-8): 875-886
Bernstein, H.H.; Garrison, K.; Marchant, C.D. 1997: Safety and immunogenicity of diphtheria-tetanus-acellular pertussis vaccine adsorbed , Connaught diphtheria-tetanus-acellular pertussis vaccine adsorbed , and diphtheria-tetanus-pertussis vaccine adsorbed in 2,4, and 6 month old infants Pediatric Research 41(4 Part 2): 117A
Mosley, Y.-Y.C.; Radder, J.E.; HogenEsch, H. 2019: Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice Vaccines 7(4)
John, T.; Voysey, M.; Yu, L.M.; McCarthy, N.; Baudin, M.; Richard, P.; Fiquet, A.; Kitchin, N.; Pollard, A.J. 2015: Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: a 5-year follow-up of a randomised controlled study Vaccine 33(36): 4579-4585
Gupta, R.K.; Anderson, R.; Cecchini, D.; Rost, B.; Xu, J.; Gendreau, K.; Saroff, D.L.; Marchant, C.; Siber, G.R. 1999: Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine Biologicals: Journal of the International Association of Biological Standardization 27(2): 167-176